- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有101家主力机构披露2025-06-30报告期持股数据，持仓量总计3663.27万股，占流通A股7.47%
- 波段诊断：
-
技术面诊股
诊断结果：7.1技术面打败了61%的股票
技术面评分前10的股票
近期的平均成本为12.15元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为12.15元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"12.15","date":1757924011,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2025.09.16","stock":"0.08","trade":null,"ind":"0.45"},{"date":"2025.09.15","stock":"-0.65","trade":null,"ind":"0.63"},{"date":"2025.09.12","stock":"-0.16","trade":null,"ind":"-0.43"},{"date":"2025.09.11","stock":"0.49","trade":null,"ind":"3.36"},{"date":"2025.09.10","stock":"-0.41","trade":null,"ind":"0.38"},{"date":"2025.09.09","stock":"-1.60","trade":null,"ind":"-1.23"},{"date":"2025.09.08","stock":"2.47","trade":null,"ind":"0.61"},{"date":"2025.09.05","stock":"1.25","trade":null,"ind":"3.89"},{"date":"2025.09.04","stock":"0.50","trade":null,"ind":"-2.83"},{"date":"2025.09.03","stock":"-1.89","trade":null,"ind":"-0.65"},{"date":"2025.09.02","stock":"-1.14","trade":null,"ind":"-2.14"},{"date":"2025.09.01","stock":"0.57","trade":null,"ind":"1.05"},{"date":"2025.08.29","stock":"-1.05","trade":null,"ind":"0.99"},{"date":"2025.08.28","stock":"-1.04","trade":null,"ind":"2.25"},{"date":"2025.08.27","stock":"-3.02","trade":null,"ind":"-1.43"},{"date":"2025.08.26","stock":"-0.15","trade":null,"ind":"0.26"},{"date":"2025.08.25","stock":"0.86","trade":null,"ind":"2.26"},{"date":"2025.08.22","stock":"-0.16","trade":null,"ind":"2.07"},{"date":"2025.08.21","stock":"0.31","trade":null,"ind":"-0.06"},{"date":"2025.08.20","stock":"-0.08","trade":null,"ind":"0.89"},{"date":"2025.08.19","stock":"1.18","trade":null,"ind":"-0.12"}]
迈克生物,深证成指,医疗器械指数
压力支撑
该股压力位为12.13元，支撑位为12.05元。
[{"text":"\u538b\u529b\u4f4d","value":"12.13","date":1757952000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.05","date":1757952000,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.0资金面打败了38%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：09月16日 20:30
| 机构今日流向(万元) | 89.00 | 机构5日流向(万元) | -2379.25 |
| 机构10日流向(万元) | -5934.17 | 机构20日流向(万元) | -19824.81 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加11.61万股，其中基金净减仓15家，主力净减仓9家，暂未发现中长期投资价值。
截止2025-06-30，共101家主力机构（基金97家，一般法人3家，QFII1家），持仓量总计3663.27万股，占流通A股7.47%
其中，基金持仓与2024-12-31相比：
增仓：20家 ，增持 224.80万股
减仓：35家 ，减持 97.80万股
新出现在主力名单中：38家 ，持有645.46万股
从主力名单中消失：47家 ，原持有140.81万股
其中，基金持仓与2024-12-31相比：
增仓：20家 ，增持 224.80万股
减仓：35家 ，减持 97.80万股
新出现在主力名单中：38家 ，持有645.46万股
从主力名单中消失：47家 ，原持有140.81万股
消息面诊股
诊断结果：5.5消息面打败了33%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 迈克生物：9月15日获融资买入545.71万元
2025-09-16 - 迈克生物：9月12日获融资买入940.52万元
2025-09-15 - 迈克生物：9月11日获融资买入973.76万元，占
2025-09-12 - 迈克生物：9月10日获融资买入1117.28万元
2025-09-11 - 回购增持双升温，传递市场积极信号
2025-09-10 - 迈克生物：9月9日获融资买入1104.40万元
2025-09-10 - 迈克生物：公司将持续深化人工智能技术在体外诊断领域
2025-09-09 - 研判2025！中国生化诊断行业产业链、相关政策和市
2025-09-09 - 迈克生物：9月8日获融资买入1478.65万元，占
2025-09-09 - 迈克生物：9月5日获融资买入897.38万元，占当
2025-09-08
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2025-09-03 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-01 |
| 一般消息 | 募资投向 | 预测年新增净利润为:43839.... | 2025-08-01 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-06-12 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-06-12 |
| 利好 | 分红转增 | 10派1.04元(含税) | 2025-04-29 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-04-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-04-29 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-14 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了2%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2025.09.16","price":"0.45","value":null},{"date":"2025.09.15","price":"0.63","value":null},{"date":"2025.09.12","price":"-0.43","value":null},{"date":"2025.09.11","price":"3.36","value":null},{"date":"2025.09.10","price":"0.38","value":null},{"date":"2025.09.09","price":"-1.23","value":null},{"date":"2025.09.08","price":"0.61","value":null},{"date":"2025.09.05","price":"3.89","value":null},{"date":"2025.09.04","price":"-2.83","value":null},{"date":"2025.09.03","price":"-0.65","value":null},{"date":"2025.09.02","price":"-2.14","value":null},{"date":"2025.09.01","price":"1.05","value":null},{"date":"2025.08.29","price":"0.99","value":null},{"date":"2025.08.28","price":"2.25","value":null},{"date":"2025.08.27","price":"-1.43","value":null},{"date":"2025.08.26","price":"0.26","value":null},{"date":"2025.08.25","price":"2.26","value":null},{"date":"2025.08.22","price":"2.07","value":null},{"date":"2025.08.21","price":"-0.06","value":null},{"date":"2025.08.20","price":"0.89","value":null},{"date":"2025.08.19","price":"-0.12","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 天臣医疗 | 67.24% | 19.57% | 6.6分 |
| 2 | 振德医疗 | 61.29% | 31.27% | 5.9分 |
| 3 | 浩欧博 | 39.63% | 14.64% | 5.4分 |
| 4 | 美好医疗 | 39.51% | 13.61% | 6.3分 |
| 5 | 奥精医疗 | 32.34% | 7.26% | 5.4分 |
| 6 | 济民健康 | 27.83% | 9.80% | 5.3分 |
| 8 | 福瑞股份 | 18.84% | 34.88% | 6.5分 |
| 10 | 新产业 | 16.37% | -1.12% | 5.9分 |
| 12 | 硕世生物 | 14.22% | 16.05% | 5.9分 |
| 14 | 五洲医疗 | 13.88% | 5.17% | 5.2分 |
| 16 | 采纳股份 | 10.43% | 20.30% | 6.0分 |
| 18 | 乐普医疗 | 6.25% | 5.21% | 5.3分 |
| 20 | 万东医疗 | 4.95% | 2.14% | 6.3分 |
| 22 | 惠泰医疗 | 3.91% | -3.37% | 5.9分 |
| 24 | 开立医疗 | 3.41% | -1.24% | 5.0分 |
| 26 | 康德莱 | 3.19% | -1.37% | 5.8分 |
| 28 | 迈瑞医疗 | 2.89% | -0.58% | 5.3分 |
| 30 | 春立医疗 | 2.44% | -1.72% | 6.5分 |
| 32 | 华大智造 | 1.15% | 1.29% | 5.4分 |
| 34 | 拱东医疗 | 0.00% | 1.19% | 6.2分 |
| 36 | 威高血净 | -0.27% | -1.55% | 5.7分 |
| 38 | 健帆生物 | -0.55% | -3.34% | 5.1分 |
| 40 | 康众医疗 | -0.85% | -2.95% | 4.8分 |
| 42 | 东星医疗 | -1.44% | -1.73% | 5.1分 |
| 44 | 健尔康 | -2.07% | 0.47% | 5.1分 |
| 46 | 戴维医疗 | -2.19% | 0.96% | 5.5分 |
| 48 | 海利生物 | -2.32% | 0.28% | 4.7分 |
| 50 | 东方海洋 | -2.40% | 4.40% | 5.8分 |
| 52 | 维力医疗 | -2.62% | 0.49% | 6.2分 |
| 54 | 三友医疗 | -3.34% | -1.27% | 4.9分 |
| 56 | 艾德生物 | -3.52% | -5.12% | 4.9分 |
| 58 | 东富龙 | -4.02% | 1.67% | 5.7分 |
| 60 | 洁特生物 | -4.28% | -1.81% | 5.6分 |
| 62 | 睿昂基因 | -4.74% | -1.89% | 5.3分 |
| 64 | 迈克生物 | -4.84% | -0.65% | 5.2分 |
| 66 | 新华医疗 | -5.11% | -0.31% | 5.1分 |
| 68 | 海尔生物 | -5.40% | 0.88% | 5.7分 |
| 70 | 西山科技 | -5.56% | 0.46% | 5.9分 |
| 72 | 康拓医疗 | -5.58% | 0.91% | 6.3分 |
| 74 | 圣湘生物 | -5.89% | 0.78% | 5.6分 |
| 76 | 九强生物 | -6.16% | -0.79% | 5.3分 |
| 78 | 康泰医学 | -6.61% | 3.14% | 5.2分 |
| 80 | ST凯利 | -6.79% | -2.60% | 5.0分 |
| 82 | 可孚医疗 | -6.89% | -3.05% | 5.5分 |
| 84 | 正海生物 | -6.97% | 1.12% | 5.0分 |
| 86 | 冠昊生物 | -7.06% | 2.34% | 6.0分 |
| 88 | 楚天科技 | -7.23% | 0.24% | 4.8分 |
| 90 | 南卫股份 | -7.57% | -1.40% | 6.1分 |
| 92 | 迪瑞医疗 | -7.80% | -0.92% | 4.9分 |
| 94 | 美康生物 | -8.07% | 0.93% | 4.8分 |
| 96 | 天智航 | -8.49% | 1.24% | 5.9分 |
| 98 | 东方生物 | -8.64% | -0.15% | 5.3分 |
| 100 | 祥生医疗 | -8.79% | 2.89% | 6.3分 |
| 102 | 科美诊断 | -9.00% | -0.25% | 5.3分 |
| 104 | 奥泰生物 | -9.27% | -1.20% | 5.2分 |
| 106 | 阳普医疗 | -9.45% | 0.62% | 5.5分 |
| 108 | 爱朋医疗 | -9.91% | 3.70% | 4.7分 |
| 110 | 安杰思 | -10.25% | -1.51% | 5.9分 |
| 112 | 中源协和 | -11.25% | 2.53% | 4.5分 |
| 114 | 蓝帆医疗 | -11.72% | 0.85% | 5.7分 |
| 116 | 迈普医学 | -12.16% | 1.02% | 5.2分 |
| 118 | 安必平 | -12.33% | -0.18% | 5.0分 |
| 120 | 山外山 | -13.95% | -3.82% | 5.5分 |
| 122 | 利德曼 | -15.84% | 2.89% | 5.2分 |
| 124 | 华强科技 | -16.47% | 1.46% | 4.7分 |
| 126 | 尚荣医疗 | -16.92% | 2.86% | 5.3分 |
| 128 | 赛诺医疗 | -24.84% | 1.20% | 5.1分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 91/248 ， 63/248。
[{"date":"2025-06-30","value":"0.54","vol":"2.27"},{"date":"2025-03-31","value":"0.38","vol":"1.15"},{"date":"2024-12-31","value":"1.99","vol":"0.53"},{"date":"2024-09-30","value":"4.36","vol":"4.75"},{"date":"2024-06-30","value":"3.14","vol":"3.53"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.54 | 0.38 | 1.99 | 4.36 | 3.14 |
| 行业(%) | 2.27 | 1.15 | 0.53 | 4.75 | 3.53 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"56.96","vol":"52.10"},{"date":"2025-03-31","value":"56.76","vol":"51.81"},{"date":"2024-12-31","value":"55.11","vol":"52.63"},{"date":"2024-09-30","value":"57.19","vol":"53.58"},{"date":"2024-06-30","value":"57.00","vol":"53.70"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
56.96 | 56.76 | 55.11 | 57.19 | 57.00 |
| 行业(%) | 52.10 | 51.81 | 52.63 | 53.58 | 53.70 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 100/248 ， 110/248。
[{"date":"2025-06-30","value":"-15.94","vol":"-1.71"},{"date":"2025-03-31","value":"-17.22","vol":"-0.92"},{"date":"2024-12-31","value":"-11.98","vol":"0.64"},{"date":"2024-09-30","value":"-7.92","vol":"0.79"},{"date":"2024-06-30","value":"-7.37","vol":"0.16"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-15.94 | -17.22 | -11.98 | -7.92 | -7.37 |
| 行业(%) | -1.71 | -0.92 | 0.64 | 0.79 | 0.16 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-83.12","vol":"-20.27"},{"date":"2025-03-31","value":"-80.09","vol":"-4.25"},{"date":"2024-12-31","value":"-59.44","vol":"-24.11"},{"date":"2024-09-30","value":"4.72","vol":"-20.40"},{"date":"2024-06-30","value":"15.38","vol":"8.56"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-83.12 | -80.09 | -59.44 | 4.72 | 15.38 |
| 行业(%) | -20.27 | -4.25 | -24.11 | -20.40 | 8.56 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 80/248 ， 109/248。
[{"date":"2025-06-30","value":"0.13","vol":"0.17"},{"date":"2025-03-31","value":"0.06","vol":"0.08"},{"date":"2024-12-31","value":"0.32","vol":"0.35"},{"date":"2024-09-30","value":"0.24","vol":"0.26"},{"date":"2024-06-30","value":"0.16","vol":"0.18"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.13 | 0.06 | 0.32 | 0.24 | 0.16 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.26 | 0.18 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.48","vol":"1.13"},{"date":"2025-03-31","value":"0.24","vol":"0.55"},{"date":"2024-12-31","value":"1.26","vol":"2.33"},{"date":"2024-09-30","value":"0.87","vol":"1.67"},{"date":"2024-06-30","value":"0.58","vol":"1.13"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.48 | 0.24 | 1.26 | 0.87 | 0.58 |
| 行业(次) | 1.13 | 0.55 | 2.33 | 1.67 | 1.13 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 59/248 ， 98/248。
[{"date":"2025-06-30","value":"18.81","vol":"15.06"},{"date":"2025-03-31","value":"10.89","vol":"4.01"},{"date":"2024-12-31","value":"23.42","vol":"29.58"},{"date":"2024-09-30","value":"41.92","vol":"15.37"},{"date":"2024-06-30","value":"31.36","vol":"13.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 18.81 | 10.89 | 23.42 | 41.92 | 31.36 |
| 行业 | 15.06 | 4.01 | 29.58 | 15.37 | 13.04 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.14","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.84","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"3.19","vol":"2.31"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 2.14 | - | 2.84 | - | 3.19 |
| 行业 | 1.57 | 0.00 | 2.19 | 0.01 | 2.31 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 51/248 ， 37/248。
[{"date":"2025-06-30","value":"3.50","vol":"5.50"},{"date":"2025-03-31","value":"2.96","vol":"5.89"},{"date":"2024-12-31","value":"3.04","vol":"5.34"},{"date":"2024-09-30","value":"3.15","vol":"5.97"},{"date":"2024-06-30","value":"3.34","vol":"5.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.50 | 2.96 | 3.04 | 3.15 | 3.34 |
| 行业 | 5.50 | 5.89 | 5.34 | 5.97 | 5.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.05","vol":"4.40"},{"date":"2025-03-31","value":"1.83","vol":"4.77"},{"date":"2024-12-31","value":"1.96","vol":"4.32"},{"date":"2024-09-30","value":"2.07","vol":"4.82"},{"date":"2024-06-30","value":"2.27","vol":"4.90"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.05 | 1.83 | 1.96 | 2.07 | 2.27 |
| 行业 | 4.40 | 4.77 | 4.32 | 4.82 | 4.90 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 54/248 ， 55/248。
[{"date":"2025-06-30","value":"20.45","vol":"22.01"},{"date":"2025-03-31","value":"20.27","vol":"21.24"},{"date":"2024-12-31","value":"19.47","vol":"21.92"},{"date":"2024-09-30","value":"19.35","vol":"21.09"},{"date":"2024-06-30","value":"19.33","vol":"21.07"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
20.45 | 20.27 | 19.47 | 19.35 | 19.33 |
| 行业(%) | 22.01 | 21.24 | 21.92 | 21.09 | 21.07 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.26","vol":"0.58"},{"date":"2025-03-31","value":"0.26","vol":"0.57"},{"date":"2024-12-31","value":"0.24","vol":"0.55"},{"date":"2024-09-30","value":"0.24","vol":"0.38"},{"date":"2024-06-30","value":"0.25","vol":"0.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.26 | 0.26 | 0.24 | 0.24 | 0.25 |
| 行业(%) | 0.58 | 0.57 | 0.55 | 0.38 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"9.57","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"7.08","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.13","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.27","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.54","blueLineValue":"0.42","type":"YC"}]